Fagron N.V. : Another strong quarter as results top expectations
>Fagron reported another strong set of results - Fagron reported a strong set of Q3 results where group sales for the quarter came at €214.5m, 12.1% higher year on year (yoy) and up 3% from company compiled consensus (css) and around 7% higher than our estimate of €201m. On a regional level, EMEA reported sales of €73.6m, up 11.2% yoy, 1% higher than consensus and 8.5% higher than AA-OB estimate of €68m. For Latin America, sales came at €44.1m, down 2.6% yoy, 5% above...Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.